HUMAN UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELLS IMPROVE CARDIAC FUNCTION IN CTNTR141W TRANSGENIC MOUSE MODEL OF DILATED CARDIOMYOPATHY THROUGH MULTIPLE MECHANISMS  by Gong, Xuhe & Wang, Guogan
Heart Failure and Cardiomyopathies
A852
JACC March 17, 2015
Volume 65, Issue 10S
humAn umBIlIcAl cord Blood derIved mesenchymAl stem cells ImProve cArdIAc 
functIon In ctntr141w trAnsgenIc mouse model of dIlAted cArdIomyoPAthy through 
multIPle mechAnIsms
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Stems Cells and Cardiac Regeneration
Abstract Category: 13.  Heart Failure and Cardiomyopathies: Basic
Presentation Number: 1144-181
Authors: Xuhe Gong, Guogan Wang, Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, People’s Republic of China, 
Chinese Academy of Medical Sciences and Peking Union Medical College, Bejing, People’s Republic of China
Background:  Cell transplantation is a promising strategy in regenerative medicine,the beneficial effects of bone marrow mesenchymal 
stem cells (BM-MSCs) in the heart diseases are widely reported, however, MSCs in these studies are animal autogenous derived, 
data are still scarce on MSCs from human umbilical cord blood(UCB-MSCs). We investigated whether the intramyocardial xenogeneic 
administration of UCB-MSCs offers benefit in preserving heart function in cTnTR141W transgenic mouse model of dilated cardiomyopathy 
(DCM). 
methods:  Cultured UCB-MSCs, which were identified by morphology, differentiation and cell surface markers, were transplanted into 
cTnTR141W transgenic mouse to examine apoptosis, fibrosis, vasculogenesis and their associated Akt pathway. We also determined 
levels of VEGF and IGF-1, growth factors required for their differentiation into cardiacmyocytes, which also contributes in cardiac 
regeneration and improved heart function. Moreover, medium produced by MSCs preconditioned under normoxia or hypoxia was collected 
for subsequent in vitro assays. 
results:  MSCs significantly decreased chamber dilation and contractile dysfunction in cTnTR141W mouse. MSCs transplanted 
hearts showed a significant decrease in cardiac apoptosis and their regulation with Akt pathway. Cardiac fibrosis and cytoplasmic 
vacuolization in the MSCs group was significantly lower. Importantly, the levels of VEGF and IGF-1 were increased in MSCs transplanted 
hearts, suggesting endogenous cardiac regeneration. In vitro, the MSC-conditioned medium displayed anti-apoptotic activity in h9c2 
cardiomyocytes subjected to hypoxia, further confirmed the paracrine effects of MSCs. 
conclusion:  UCB-MSCs preserve cardiac function after intramyocardial transplantation in a DCM mouse model, which may be associated 
with inhibition of cellular apoptosis, inflammatory, up-regulated expressions of Akt, VEGF, IGF-1 and enhanced angiogenesis.
